Interestingly, we found that MCP-1 levels were significantly decreased with the treatment of 17β-estradiol in healthy control cells (Figure 5I), in contrast to SLE patients’ cells in which 17β-estradiol treatment significantly increased MCP-1 levels (Figure 5J). Here, CCL2 is linked to systemic lupus erythematosus.